Double Reducer implantation in the coronary venous system for treatment of refractory angina: a case report.
Angina
Case report
Coronary sinus
Coronary sinus Reducer
Revascularization
Journal
European heart journal. Case reports
ISSN: 2514-2119
Titre abrégé: Eur Heart J Case Rep
Pays: England
ID NLM: 101730741
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
10
12
2021
revised:
10
01
2022
accepted:
19
05
2022
entrez:
8
6
2022
pubmed:
9
6
2022
medline:
9
6
2022
Statut:
epublish
Résumé
The coronary sinus (CS) Reducer can be considered for the treatment of refractory angina in patients unsuitable for coronary revascularization, but its effect can be influenced by the significant heterogeneity in the anatomy of the cardiac venous system. We report the case of a 70-year-old woman with recurrent episodes of rest angina refractory to optimal medical therapy [Canadian Cardiovascular Society (CCS) Class IV] and inducible ischaemia in a large myocardial territory. Given the diffuse and peripheral nature of the coronary disease, the patient was considered ineligible for percutaneous or surgical revascularization and she was regarded as a good candidate for a CS occluder. Since coronary venous angiography showed the middle cardiac vein (MCV) to be at least as relevant as the CS, successful implantation of two devices, one in the CS and the second in the MCV, was performed. At 6-month follow-up, the patient reported a significant improvement in angina, resulting in a reduction of the CCS class from Grades IV to III. In patients affected by refractory angina and regarded as good candidates for Reducer implantation, a thorough comprehension of the cardiac venous pathway drainage is of pivotal importance to guarantee the therapeutic success of the procedure. In this patient, since the CS and the MCV seemed to contribute equally to coronary venous drainage, Reducer implantation in both vessels allowed to obtain a significant improvement of symptoms. The clinical effectiveness of this strategy needs to be validated in randomized clinical trials.
Sections du résumé
Background
UNASSIGNED
The coronary sinus (CS) Reducer can be considered for the treatment of refractory angina in patients unsuitable for coronary revascularization, but its effect can be influenced by the significant heterogeneity in the anatomy of the cardiac venous system.
Case summary
UNASSIGNED
We report the case of a 70-year-old woman with recurrent episodes of rest angina refractory to optimal medical therapy [Canadian Cardiovascular Society (CCS) Class IV] and inducible ischaemia in a large myocardial territory. Given the diffuse and peripheral nature of the coronary disease, the patient was considered ineligible for percutaneous or surgical revascularization and she was regarded as a good candidate for a CS occluder. Since coronary venous angiography showed the middle cardiac vein (MCV) to be at least as relevant as the CS, successful implantation of two devices, one in the CS and the second in the MCV, was performed. At 6-month follow-up, the patient reported a significant improvement in angina, resulting in a reduction of the CCS class from Grades IV to III.
Discussion
UNASSIGNED
In patients affected by refractory angina and regarded as good candidates for Reducer implantation, a thorough comprehension of the cardiac venous pathway drainage is of pivotal importance to guarantee the therapeutic success of the procedure. In this patient, since the CS and the MCV seemed to contribute equally to coronary venous drainage, Reducer implantation in both vessels allowed to obtain a significant improvement of symptoms. The clinical effectiveness of this strategy needs to be validated in randomized clinical trials.
Identifiants
pubmed: 35673278
doi: 10.1093/ehjcr/ytac210
pii: ytac210
pmc: PMC9168669
doi:
Types de publication
Case Reports
Langues
eng
Pagination
ytac210Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.
Références
EuroIntervention. 2018 Feb 20;13(14):1667-1669
pubmed: 29086709
Clin Anat. 2009 Jan;22(1):129-45
pubmed: 19097063
JACC Cardiovasc Interv. 2020 Jan 13;13(1):1-19
pubmed: 31918927
Am J Cardiol. 2021 Jan 15;139:22-27
pubmed: 32998007
Ann Anat. 2003 Dec;185(6):535-42
pubmed: 14703998
J Invasive Cardiol. 2018 Aug;30(8):E69-E70
pubmed: 30068789
J Invasive Cardiol. 2021 Nov;33(11):E884-E889
pubmed: 34544037
Kardiol Pol. 2022;80(1):25-32
pubmed: 34643262
J Am Coll Cardiol. 1995 Feb;25(2):333-41
pubmed: 7829785
N Engl J Med. 2015 Feb 5;372(6):519-27
pubmed: 25651246
Catheter Cardiovasc Interv. 2020 Mar 1;95(4):718-721
pubmed: 31721392
Circ Cardiovasc Imaging. 2019 Sep;12(9):e009148
pubmed: 31451003
Eur Heart J. 2021 Jan 20;42(3):269-283
pubmed: 33367764